Finding Needles in the Haystack: Strategies for Uncovering Noncoding Regulatory Variants

Literature Cited

1. 1.

   1000 Genomes Proj. Consort., Auton A, Brooks LD, Durbin RM, Garrison EP et al. 2015. A global reference for human genetic variation. Nature 526:757168–74
   [Google Scholar]
2. 2.

   Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A et al. 2010. A method and server for predicting damaging missense mutations. Nat. Methods 7:4248–49
   [Google Scholar]
3. 3.

   Agarwal V, Shendure J. 2020. Predicting mRNA abundance directly from genomic sequence using deep convolutional neural networks. Cell Rep. 31:7107663
   [Google Scholar]
4. 4.

   Alipanahi B, Delong A, Weirauch MT, Frey BJ. 2015. Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning. Nat. Biotechnol. 33:8831–38
   [Google Scholar]
5. 5.

   Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J et al. 2014. An atlas of active enhancers across human cell types and tissues. Nature 507:7493455–61
   [Google Scholar]
6. 6.

   Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW et al. 2019. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576:7785149–57
   [Google Scholar]
7. 7.

   Arnold CD, Gerlach D, Stelzer C, Boryń ŁM, Rath M, Stark A. 2013. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339:61231074–77
   [Google Scholar]
8. 8.

   Avsec Ž, Agarwal V, Visentin D, Ledsam JR, Grabska-Barwinska A et al. 2021. Effective gene expression prediction from sequence by integrating long-range interactions. Nat. Methods 18:101196–203
   [Google Scholar]
9. 9.

   Avsec Ž, Weilert M, Shrikumar A, Krueger S, Alexandari A et al. 2021. Base-resolution models of transcription-factor binding reveal soft motif syntax. Nat. Genet. 53:3354–66
   [Google Scholar]
10. 10.

    Bell O, Tiwari VK, Thomä NH, Schübeler D. 2011. Determinants and dynamics of genome accessibility. Nat. Rev. Genet. 12:8554–64
    [Google Scholar]
11. 11.

    Bishop CM. 2006. Pattern Recognition and Machine Learning New York: Springer
12. 12.

    Bocher O, Génin E. 2020. Rare variant association testing in the non-coding genome. Hum. Genet. 139:111345–62
    [Google Scholar]
13. 13.

    Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH et al. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell 132:2311–22
    [Google Scholar]
14. 14.

    Bravo González-Blas C, Quan X-J, Duran-Romaña R, Taskiran II, Koldere D et al. 2020. Identification of genomic enhancers through spatial integration of single-cell transcriptomics and epigenomics. Mol. Syst. Biol. 16:5e9438
    [Google Scholar]
15. 15.

    Breheny P, Huang J. 2009. Penalized methods for bi-level variable selection. Stat. Interface 2:3369–80
    [Google Scholar]
16. 16.

    Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. 2013. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10:121213–18
    [Google Scholar]
17. 17.

    Campbell CT, Kim G. 2007. SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics. Biomaterials 28:152380–92
    [Google Scholar]
18. 18.

    Cano-Gamez E, Trynka G. 2020. From GWAS to function: using functional genomics to identify the mechanisms underlying complex diseases. Front. Genet. 11:424
    [Google Scholar]
19. 19.

    Caron B, Luo Y, Rausell A. 2019. NCBoost classifies pathogenic non-coding variants in Mendelian diseases through supervised learning on purifying selection signals in humans. Genome Biol. 20:132
    [Google Scholar]
20. 20.

    Carroll D. 2011. Genome engineering with zinc-finger nucleases. Genetics 188:4773–82
    [Google Scholar]
21. 21.

    Chen KM, Wong AK, Troyanskaya OG, Zhou J. 2022. A sequence-based global map of regulatory activity for deciphering human genetics. Nat. Genet. 54:7940–49
    [Google Scholar]
22. 22.

    Chen SP, Wang HH. 2019. An engineered Cas-Transposon system for programmable and site-directed DNA transpositions. CRISPR J. 2:6376–94
    [Google Scholar]
23. 23.

    Chen W, Larrabee BR, Ovsyannikova IG, Kennedy RB, Haralambieva IH et al. 2015. Fine mapping causal variants with an approximate Bayesian method using marginal test statistics. Genetics 200:3719–36
    [Google Scholar]
24. 24.

    Cho S, Kim H, Oh S, Kim K, Park T. 2009. Elastic-net regularization approaches for genome-wide association studies of rheumatoid arthritis. BMC Proc. 3:Suppl. 7S25
    [Google Scholar]
25. 25.

    Cochran JN, Geier EG, Bonham LW, Newberry JS, Amaral MD et al. 2020. Non-coding and loss-of-function coding variants in TET2 are associated with multiple neurodegenerative diseases. Am. J. Hum. Genet. 106:5632–45
    [Google Scholar]
26. 26.

    Connally NJ, Nazeen S, Lee D, Shi H, Stamatoyannopoulos J et al. 2022. The missing link between genetic association and regulatory function. eLife 11:e74970
    [Google Scholar]
27. 27.

    Core LJ, Martins AL, Danko CG, Waters CT, Siepel A, Lis JT. 2014. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat. Genet. 46:121311–20
    [Google Scholar]
28. 28.

    Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. 2010. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLOS Comput. Biol. 6:12e1001025
    [Google Scholar]
29. 29.

    Derkach A, Lawless JF, Sun L. 2014. Pooled association tests for rare genetic variants: a review and some new results. Stat. Sci. 29:2302–21
    [Google Scholar]
30. 30.

    di Iulio J, Bartha I, Wong EHM, Yu H-C, Lavrenko V et al. 2018. The human noncoding genome defined by genetic diversity. Nat. Genet. 50:3333–37
    [Google Scholar]
31. 31.

    Doudna JA, Charpentier E. 2014. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346:62131258096
    [Google Scholar]
32. 32.

    ENCODE Proj. Consort 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:741457–74
    [Google Scholar]
33. 33.

    Epinat J-C, Arnould S, Chames P, Rochaix P, Desfontaines D et al. 2003. A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells. Nucleic Acids Res. 31:112952–62
    [Google Scholar]
34. 34.

    Ernst J, Kellis M. 2012. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9:3215–16
    [Google Scholar]
35. 35.

    Ernst J, Kellis M. 2017. Chromatin-state discovery and genome annotation with ChromHMM. Nat. Protoc. 12:122478–92
    [Google Scholar]
36. 36.

    Esrick EB, Lehmann LE, Biffi A, Achebe M, Brendel C et al. 2021. Post-transcriptional genetic silencing of BCL11A to treat sickle cell disease. N. Engl. J. Med. 384:3205–15
    [Google Scholar]
37. 37.

    Frangoul H, Altshuler D, Cappellini MD, Chen Y-S, Domm J et al. 2021. CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N. Engl. J. Med. 384:3252–60
    [Google Scholar]
38. 38.

    Fudenberg G, Kelley DR, Pollard KS. 2020. Predicting 3D genome folding from DNA sequence with Akita. Nat. Methods 17:111111–17
    [Google Scholar]
39. 39.

    Fulco CP, Nasser J, Jones TR, Munson G, Bergman DT et al. 2019. Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations. Nat. Genet. 51:121664–69
    [Google Scholar]
40. 40.

    Gallagher MD, Chen-Plotkin AS. 2018. The post-GWAS era: from association to function. Am. J. Hum. Genet. 102:5717–30
    [Google Scholar]
41. 41.

    Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD. 2007. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res. 17:6877–85
    [Google Scholar]
42. 42.

    Gong J, Mei S, Liu C, Xiang Y, Ye Y et al. 2018. PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types. Nucleic Acids Res. 46:D1D971–76
    [Google Scholar]
43. 43.

    Hardison RC, Taylor J. 2012. Genomic approaches towards finding cis-regulatory modules in animals. Nat. Rev. Genet. 13:7469–83
    [Google Scholar]
44. 44.

    Hayashi T, Ozaki H, Sasagawa Y, Umeda M, Danno H, Nikaido I. 2018. Single-cell full-length total RNA sequencing uncovers dynamics of recursive splicing and enhancer RNAs. Nat. Commun. 9:1619
    [Google Scholar]
45. 45.

    He Z, Xu B, Buxbaum J, Ionita-Laza I. 2019. A genome-wide scan statistic framework for whole-genome sequence data analysis. Nat. Commun. 10:13018
    [Google Scholar]
46. 46.

    Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39:3311–18
    [Google Scholar]
47. 47.

    Hess GT, Tycko J, Yao D, Bassik MC. 2017. Methods and applications of CRISPR-mediated base editing in eukaryotic genomes. Mol. Cell 68:126–43
    [Google Scholar]
48. 48.

    Hoggart CJ, Whittaker JC, De Iorio M, Balding DJ. 2008. Simultaneous analysis of all SNPs in genome-wide and re-sequencing association studies. PLOS Genet. 4:7e1000130
    [Google Scholar]
49. 49.

    Hormozdiari F, Kostem E, Kang EY, Pasaniuc B, Eskin E. 2014. Identifying causal variants at loci with multiple signals of association. Genetics 198:2497–508
    [Google Scholar]
50. 50.

    Hormozdiari F, van de Bunt M, Segrè AV, Li X, Joo JWJ et al. 2016. Colocalization of GWAS and eQTL signals detects target genes. Am. J. Hum. Genet. 99:61245–60
    [Google Scholar]
51. 51.

    Huang Y-F, Gulko B, Siepel A. 2017. Fast, scalable prediction of deleterious noncoding variants from functional and population genomic data. Nat. Genet. 49:4618–24
    [Google Scholar]
52. 52.

    Inoue F, Kircher M, Martin B, Cooper GM, Witten DM et al. 2017. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity. Genome Res. 27:138–52
    [Google Scholar]
53. 53.

    Ionita-Laza I, McCallum K, Xu B, Buxbaum JD. 2016. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat. Genet. 48:2214–20
    [Google Scholar]
54. 54.

    Johnson DS, Mortazavi A, Myers RM, Wold B. 2007. Genome-wide mapping of in vivo protein-DNA interactions. Science 316:58301497–502
    [Google Scholar]
55. 55.

    Joung JK, Sander JD. 2013. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14:149–55
    [Google Scholar]
56. 56.

    Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J et al. 2020. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:7809434–43
    [Google Scholar]
57. 57.

    Kelley DR, Reshef YA, Bileschi M, Belanger D, McLean CY, Snoek J. 2018. Sequential regulatory activity prediction across chromosomes with convolutional neural networks. Genome Res. 28:5739–50
    [Google Scholar]
58. 58.

    Kelley DR, Snoek J, Rinn JL. 2016. Basset: learning the regulatory code of the accessible genome with deep convolutional neural networks. Genome Res. 26:7990–99
    [Google Scholar]
59. 59.

    Kim T, Wei P. 2016. Incorporating ENCODE information into association analysis of whole genome sequencing data. BMC Proc. 10:Suppl. 79
    [Google Scholar]
60. 60.

    Kim T-K, Hemberg M, Gray JM, Costa AM, Bear DM et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465:7295182–87
    [Google Scholar]
61. 61.

    Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46:3310–15
    [Google Scholar]
62. 62.

    Klein JC, Agarwal V, Inoue F, Keith A, Martin B et al. 2020. A systematic evaluation of the design and context dependencies of massively parallel reporter assays. Nat. Methods 17:111083–91
    [Google Scholar]
63. 63.

    Klompe SE, Vo PLH, Halpin-Healy TS, Sternberg SH. 2019. Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration. Nature 571:7764219–25
    [Google Scholar]
64. 64.

    Komor AC, Badran AH, Liu DR. 2017. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 168:1–220–36
    [Google Scholar]
65. 65.

    Kouno T, Moody J, Kwon AT-J, Shibayama Y, Kato S et al. 2019. C1 CAGE detects transcription start sites and enhancer activity at single-cell resolution. Nat. Commun. 10:1360
    [Google Scholar]
66. 66.

    Kouzarides T. 2007. Chromatin modifications and their function. Cell 128:4693–705
    [Google Scholar]
67. 67.

    Kurdistani SK, Grunstein M. 2003. In vivo protein–protein and protein–DNA crosslinking for genomewide binding microarray. Methods 31:190–95
    [Google Scholar]
68. 68.

    Kurt IC, Zhou R, Iyer S, Garcia SP, Miller BR et al. 2021. CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nat. Biotechnol. 39:141–46
    [Google Scholar]
69. 69.

    Ladouceur M, Dastani Z, Aulchenko YS, Greenwood CMT, Richards JB. 2012. The empirical power of rare variant association methods: results from Sanger sequencing in 1,998 individuals. PLOS Genet. 8:2e1002496
    [Google Scholar]
70. 70.

    Lanchantin J, Qi Y. 2020. Graph convolutional networks for epigenetic state prediction using both sequence and 3D genome data. Bioinformatics 36:Suppl. 2i659–67
    [Google Scholar]
71. 71.

    Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B et al. 2020. ClinVar: improvements to accessing data. Nucleic Acids Res. 48:D1D835–44
    [Google Scholar]
72. 72.

    Lee D, Gorkin DU, Baker M, Strober BJ, Asoni AL et al. 2015. A method to predict the impact of regulatory variants from DNA sequence. Nat. Genet. 47:8955–61
    [Google Scholar]
73. 73.

    Lee D, Yang J, Kim S. 2022. Learning the histone codes with large genomic windows and three-dimensional chromatin interactions using transformer. Nat. Commun. 13:16678
    [Google Scholar]
74. 74.

    Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S et al. 2014. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 312:181880–87
    [Google Scholar]
75. 75.

    Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E et al. 2016. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:7616285–91
    [Google Scholar]
76. 76.

    Li G, Martínez-Bonet M, Wu D, Yang Y, Cui J et al. 2018. High-throughput identification of noncoding functional SNPs via type IIS enzyme restriction. Nat. Genet. 50:81180–88
    [Google Scholar]
77. 77.

    Liu X, Noll DM, Lieb JD, Clarke ND. 2005. DIP-chip: rapid and accurate determination of DNA-binding specificity. Genome Res. 15:3421–27
    [Google Scholar]
78. 78.

    Liu Y, Liang Y, Cicek AE, Li Z, Li J et al. 2018. A statistical framework for mapping risk genes from de novo mutations in whole-genome-sequencing studies. Am. J. Hum. Genet. 102:61031–47
    [Google Scholar]
79. 79.

    Li Z, Li X, Liu Y, Shen J, Chen H et al. 2019. Dynamic scan procedure for detecting rare-variant association regions in whole-genome sequencing studies. Am. J. Hum. Genet. 104:5802–14
    [Google Scholar]
80. 80.

    Longo SK, Guo MG, Ji AL, Khavari PA. 2021. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat. Rev. Genet. 22:10627–44
    [Google Scholar]
81. 81.

    Loos RJF. 2020. 15 years of genome-wide association studies and no signs of slowing down. Nat. Commun. 11:15900
    [Google Scholar]
82. 82.

    Lu T, Ang CE, Zhuang X. 2022. Spatially resolved epigenomic profiling of single cells in complex tissues. Cell 185:234448–64.e17
    [Google Scholar]
83. 83.

    Maerkl SJ, Quake SR. 2007. A systems approach to measuring the binding energy landscapes of transcription factors. Science 315:5809233–37
    [Google Scholar]
84. 84.

    Mangan RJ, Alsina FC, Mosti F, Sotelo-Fonseca JE, Snellings DA et al. 2022. Adaptive sequence divergence forged new neurodevelopmental enhancers in humans. Cell 185:244587–603.e23
    [Google Scholar]
85. 85.

    McKellar DW, Mantri M, Hinchman MM, Parker JSL, Sethupathy P et al. 2022. Spatial mapping of the total transcriptome by in situ polyadenylation. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01517-6
    [Google Scholar]
86. 86.

    Meng X, Brodsky MH, Wolfe SA. 2005. A bacterial one-hybrid system for determining the DNA-binding specificity of transcription factors. Nat. Biotechnol. 23:8988–94
    [Google Scholar]
87. 87.

    Moffitt JR, Hao J, Wang G, Chen KH, Babcock HP, Zhuang X. 2016. High-throughput single-cell gene-expression profiling with multiplexed error-robust fluorescence in situ hybridization. PNAS 113:3911046–51
    [Google Scholar]
88. 88.

    Molla KA, Yang Y. 2019. CRISPR/Cas-mediated base editing: technical considerations and practical applications. Trends Biotechnol. 37:101121–42
    [Google Scholar]
89. 89.

    Morrison AC, Huang Z, Yu B, Metcalf G, Liu X et al. 2017. Practical approaches for whole-genome sequence analysis of heart- and blood-related traits. Am. J. Hum. Genet. 100:2205–15
    [Google Scholar]
90. 90.

    Mostafavi H, Spence JP, Naqvi S, Pritchard JK. 2022. Limited overlap of eQTLs and GWAS hits due to systematic differences in discovery. bioRxiv 2022.05.07.491045. https://doi.org/10.1101/2022.05.07.491045
91. 91.

    Moyon L, Berthelot C, Louis A, Nguyen NTT, Roest Crollius H. 2022. Classification of non-coding variants with high pathogenic impact. PLOS Genet. 18:4e1010191
    [Google Scholar]
92. 92.

    Muerdter F, Boryń ŁM, Arnold CD. 2015. STARR-seq—principles and applications. Genomics 106:3145–50
    [Google Scholar]
93. 93.

    Nair S, Kim DS, Perricone J, Kundaje A. 2019. Integrating regulatory DNA sequence and gene expression to predict genome-wide chromatin accessibility across cellular contexts. Bioinformatics 35:14i108–16
    [Google Scholar]
94. 94.

    Nasser J, Bergman DT, Fulco CP, Guckelberger P, Doughty BR et al. 2021. Genome-wide enhancer maps link risk variants to disease genes. Nature 593:7858238–43
    [Google Scholar]
95. 95.

    Nathan A, Asgari S, Ishigaki K, Valencia C, Amariuta T et al. 2022. Single-cell eQTL models reveal dynamic T cell state dependence of disease loci. Nature 606:7912120–28
    [Google Scholar]
96. 96.

    Neale BM, Rivas MA, Voight BF, Altshuler D, Devlin B et al. 2011. Testing for an unusual distribution of rare variants. PLOS Genet. 7:3e1001322
    [Google Scholar]
97. 97.

    Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M et al. 2019. Brain cell type–specific enhancer–promoter interactome maps and disease-risk association. Science 366:64691134–39
    [Google Scholar]
98. 98.

    Park PJ. 2009. ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 10:10669–80
    [Google Scholar]
99. 99.

    Paul S, Vadgama P, Ray AK. 2009. Surface plasmon resonance imaging for biosensing. IET Nanobiotechnol. 3:371–80
    [Google Scholar]
100. 100.

     Persyn E, Karakachoff M, Le Scouarnec S, Le Clézio C, Campion D et al. 2017. DoEstRare: a statistical test to identify local enrichments in rare genomic variants associated with disease. PLOS ONE 12:7e0179364
     [Google Scholar]
101. 101.

     Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. 2010. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 20:1110–21
     [Google Scholar]
102. 102.

     Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS et al. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152:51173–83
     [Google Scholar]
103. 103.

     Rao S, Yao Y, Bauer DE. 2021. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation. Genome Med. 13:141
     [Google Scholar]
104. 104.

     Rees HA, Liu DR. 2018. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19:12770–88
     [Google Scholar]
105. 105.

     Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. 2019. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47:D1D886–94
     [Google Scholar]
106. 106.

     Rheinbay E, Nielsen MM, Abascal F, Wala JA, Shapira O et al. 2020. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578:7793102–11
     [Google Scholar]
107. 107.

     Ritchie GRS, Dunham I, Zeggini E, Flicek P. 2014. Functional annotation of noncoding sequence variants. Nat. Methods 11:3294–96
     [Google Scholar]
108. 108.

     Roulet E, Busso S, Camargo AA, Simpson AJG, Mermod N, Bucher P. 2002. High-throughput SELEX–SAGE method for quantitative modeling of transcription-factor binding sites. Nat. Biotechnol. 20:8831–35
     [Google Scholar]
109. 109.

     Sarnowski C, Satizabal CL, DeCarli C, Pitsillides AN, Cupples LA et al. 2018. Whole genome sequence analyses of brain imaging measures in the Framingham Study. Neurology 90:3e188–96
     [Google Scholar]
110. 110.

     Schaid DJ, Chen W, Larson NB. 2018. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19:8491–504
     [Google Scholar]
111. 111.

     Schmidt D, Wilson MD, Ballester B, Schwalie PC, Brown GD et al. 2010. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 328:59811036–40
     [Google Scholar]
112. 112.

     Schoenfelder S, Fraser P. 2019. Long-range enhancer–promoter contacts in gene expression control. Nat. Rev. Genet. 20:8437–55
     [Google Scholar]
113. 113.

     Schones DE, Cui K, Cuddapah S, Roh T-Y, Barski A et al. 2008. Dynamic regulation of nucleosome positioning in the human genome. Cell 132:5887–98
     [Google Scholar]
114. 114.

     Sherry ST, Ward M-H, Kholodov M, Baker J, Phan L et al. 2001. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29:1308–11
     [Google Scholar]
115. 115.

     Shihab HA, Rogers MF, Gough J, Mort M, Cooper DN et al. 2015. An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Bioinformatics 31:101536–43
     [Google Scholar]
116. 116.

     Shlyueva D, Stampfel G, Stark A. 2014. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15:4272–86
     [Google Scholar]
117. 117.

     Shumaker-Parry JS, Aebersold R, Campbell CT. 2004. Parallel, quantitative measurement of protein binding to a 120-element double-stranded DNA array in real time using surface plasmon resonance microscopy. Anal. Chem. 76:72071–82
     [Google Scholar]
118. 118.

     Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M et al. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15:81034–50
     [Google Scholar]
119. 119.

     Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. 2012. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 40:W1W452–57
     [Google Scholar]
120. 120.

     Smedley D, Schubach M, Jacobsen JOB, Köhler S, Zemojtel T et al. 2016. A whole-genome analysis framework for effective identification of pathogenic regulatory variants in Mendelian disease. Am. J. Hum. Genet. 99:3595–606
     [Google Scholar]
121. 121.

     Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. 2014. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum. Genet. 133:11–9
     [Google Scholar]
122. 122.

     Stormo GD, Zhao Y. 2010. Determining the specificity of protein–DNA interactions. Nat. Rev. Genet. 11:11751–60
     [Google Scholar]
123. 123.

     Strecker J, Ladha A, Gardner Z, Schmid-Burgk JL, Makarova KS et al. 2019. RNA-guided DNA insertion with CRISPR-associated transposases. Science 365:644848–53
     [Google Scholar]
124. 124.

     Sung YJ, Korthauer KD, Swartz MD, Engelman CD. 2014. Methods for collapsing multiple rare variants in whole-genome sequence data. Genet. Epidemiol. 38:Suppl. 1S13–20
     [Google Scholar]
125. 125.

     Tewhey R, Kotliar D, Park DS, Liu B, Winnicki S et al. 2016. Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay. Cell 165:61519–29
     [Google Scholar]
126. 126.

     Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT et al. 2012. The accessible chromatin landscape of the human genome. Nature 489:741475–82
     [Google Scholar]
127. 127.

     Tibshirani R. 1996. Regression shrinkage and selection via the lasso. J. R. Stat. Soc. 58:1267–88
     [Google Scholar]
128. 128.

     Tippens ND, Liang J, Leung AK-Y, Wierbowski SD, Ozer A et al. 2020. Transcription imparts architecture, function and logic to enhancer units. Nat. Genet. 52:101067–75
     [Google Scholar]
129. 129.

     Valouev A, Johnson SM, Boyd SD, Smith CL, Fire AZ, Sidow A. 2011. Determinants of nucleosome organization in primary human cells. Nature 474:7352516–20
     [Google Scholar]
130. 130.

     van de Bunt M, Cortes A, IGAS Consort., Brown MA, Morris AP, McCarthy MI 2015. Evaluating the performance of fine-mapping strategies at common variant GWAS loci. PLOS Genet. 11:9e1005535
     [Google Scholar]
131. 131.

     van der Wijst MGP, Brugge H, de Vries DH, Deelen P, Swertz MA et al. 2018. Single-cell RNA sequencing identifies celltype-specific cis-eQTLs and co-expression QTLs. Nat. Genet. 50:4493–97
     [Google Scholar]
132. 132.

     Vecchio-Pagán B, Blackman SM, Lee M, Atalar M, Pellicore MJ et al. 2016. Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits. Hum. Genome Var. 3:16038
     [Google Scholar]
133. 133.

     Weissbrod O, Hormozdiari F, Benner C, Cui R, Ulirsch J et al. 2020. Functionally informed fine-mapping and polygenic localization of complex trait heritability. Nat. Genet. 52:121355–63
     [Google Scholar]
134. 134.

     Werling DM, Brand H, An J-Y, Stone MR, Zhu L et al. 2018. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder. Nat. Genet. 50:5727–36
     [Google Scholar]
135. 135.

     Wilson KD, Wu JC. 2015. Induced pluripotent stem cells. JAMA 313:161613–14
     [Google Scholar]
136. 136.

     Wissink EM, Vihervaara A, Tippens ND, Lis JT. 2019. Nascent RNA analyses: tracking transcription and its regulation. Nat. Rev. Genet. 20:12705–23
     [Google Scholar]
137. 137.

     Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X. 2011. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89:182–93
     [Google Scholar]
138. 138.

     Yao L, Liang J, Ozer A, Leung AK-Y, Lis JT, Yu H. 2022. A comparison of experimental assays and analytical methods for genome-wide identification of active enhancers. Nat. Biotechnol. 40:71056–65
     [Google Scholar]
139. 139.

     Yazar S, Alquicira-Hernandez J, Wing K, Senabouth A, Gordon MG et al. 2022. Single-cell eQTL mapping identifies cell type–specific genetic control of autoimmune disease. Science 376:6589eabf3041
     [Google Scholar]
140. 140.

     Yeh CD, Richardson CD, Corn JE. 2019. Advances in genome editing through control of DNA repair pathways. Nat. Cell Biol. 21:121468–78
     [Google Scholar]
141. 141.

     Yuan G-C, Liu Y-J, Dion MF, Slack MD, Wu LF et al. 2005. Genome-scale identification of nucleosome positions in S. cerevisiae. Science 309:5734626–30
     [Google Scholar]
142. 142.

     Zhang S, Cooper-Knock J, Weimer AK, Shi M, Moll T et al. 2022. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. Neuron 110:6992–1008.e11
     [Google Scholar]
143. 143.

     Zhang Z, Feng F, Liu J. 2022. Characterizing collaborative transcription regulation with a graph-based deep learning approach. PLOS Comput. Biol. 18:6e1010162
     [Google Scholar]
144. 144.

     Zhang Z, Park CY, Theesfeld CL, Troyanskaya OG. 2021. An automated framework for efficiently designing deep convolutional neural networks in genomics. Nat. Mach. Intell. 3:5392–400
     [Google Scholar]
145. 145.

     Zhao D, Li J, Li S, Xin X, Hu M et al. 2021. Glycosylase base editors enable C-to-A and C-to-G base changes. Nat. Biotechnol. 39:135–40
     [Google Scholar]
146. 146.

     Zhao S, Hong CKY, Myers CA, Granas DM, White MA et al. 2023. A single-cell massively parallel reporter assay detects cell-type-specific gene regulation. Nat. Genet. 55:2346–54
     [Google Scholar]
147. 147.

     Zhou J. 2022. Sequence-based modeling of three-dimensional genome architecture from kilobase to chromosome scale. Nat. Genet. 54:5725–34
     [Google Scholar]
148. 148.

     Zhou J, Theesfeld CL, Yao K, Chen KM, Wong AK, Troyanskaya OG. 2018. Deep learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat. Genet. 50:81171–79
     [Google Scholar]
149. 149.

     Zhou J, Troyanskaya OG. 2015. Predicting effects of noncoding variants with deep learning–based sequence model. Nat. Methods 12:10931–34
     [Google Scholar]